Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Studies from A. Nienhaus and co-authors have provided new information about life sciences
May 21st, 2008
Data detailed in 'Evaluation of the interferon-gamma release assay in healthcare workers' have been presented. According to a study from Hamburg, Germany, "An in vitro test for the diagnosis of latent TB-infection (LTBI) is now available that has the potential to replace the tuberculin skin test (TST). The new test measures the cell-mediated immune response to TB antigens." "Little experience is currently available on the performance of the IGRA when testing HCW for LTBI. Therefore the aim of the study was to compare the IGRA with the TST in testing HCW for LTBI. The medical staffs of three hospitals were simultaneously tested with TST (RT23) and IGRA (QFT). The study...
Source: Vaccine Weekly (2008-05-21)
|
